News/ News Insilico’s AI-discovered, AI-designed IPF drug enters Phase 1 trials Jonah Comstock AI drug discovery, clinical trials, Insilico 0 Comment Hong Kong-based Insilico Medicine has begun a Phase 1 trial of its AI-discovered and AI-designed anti-fibrotic small molecule Share X Insilico’s AI-discovered, AI-designed IPF drug enters Phase 1 trials https://pharmaphorum.com/news/insilicos-ai-discovered-ai-designed-ipf-drug-enters-phase-1-trials/
